Shehadi Joseph A, Sciubba Daniel M, Suk Ian, Suki Dima, Maldaun Marcos V C, McCutcheon Ian E, Nader Remi, Theriault Richard, Rhines Laurence D, Gokaslan Ziya L
Department of Neurosurgery, M. D. Anderson Cancer Center, Houston, TX, USA.
Eur Spine J. 2007 Aug;16(8):1179-92. doi: 10.1007/s00586-007-0357-3. Epub 2007 Apr 4.
Aggressive surgical management of spinal metastatic disease can provide improvement of neurological function and significant pain relief. However, there is limited literature analyzing such management as is pertains to individual histopathology of the primary tumor, which may be linked to overall prognosis for the patient. In this study, clinical outcomes were reviewed for patients undergoing spinal surgery for metastatic breast cancer. Respective review was done to identify all patients with breast cancer over an eight-year period at a major cancer center and then to select those with symptomatic spinal metastatic disease who underwent spinal surgery. Pre- and postoperative pain levels (visual analog scale [VAS]), analgesic medication usage, and modified Frankel grade scores were compared on all patients who underwent surgery. Univariate and multivariate analyses were used to assess risks for complications. A total of 16,977 patients were diagnosed with breast cancer, and 479 patients (2.8%) were diagnosed with spinal metastases from breast cancer. Of these patients, 87 patients (18%) underwent 125 spinal surgeries. Of the 76 patients (87%) who were ambulatory preoperatively, the majority (98%) were still ambulatory. Of the 11 patients (13%) who were nonambulatory preoperatively, four patients were alive at 3 months postoperatively, three of which (75%) regained ambulation. The preoperative median VAS of six was significantly reduced to a median score of two at the time of discharge and at 3, 6, and 12 months postoperatively (P < 0.001 for all time points). A total of 39% of patients experienced complications; 87% were early (within 30 days of surgery), and 13% were late. Early major surgical complications were significantly greater when five or more levels were instrumented. In patients with spinal metastases specifically from breast cancer, aggressive surgical management provides significant pain relief and preservation or improvement of neurological function with an acceptably low rate of complications.
脊柱转移性疾病的积极手术治疗可改善神经功能并显著缓解疼痛。然而,分析这种与原发肿瘤个体组织病理学相关的治疗方法的文献有限,而原发肿瘤的组织病理学可能与患者的总体预后相关。在本研究中,对接受脊柱手术治疗转移性乳腺癌的患者的临床结局进行了回顾。进行了相应的回顾,以确定一家大型癌症中心八年内所有乳腺癌患者,然后选择那些有症状的脊柱转移性疾病并接受脊柱手术的患者。对所有接受手术的患者比较术前和术后疼痛水平(视觉模拟评分法 [VAS])、镇痛药使用情况和改良Frankel分级评分。采用单因素和多因素分析评估并发症风险。共有16977例患者被诊断为乳腺癌,479例患者(2.8%)被诊断为乳腺癌脊柱转移。在这些患者中,87例患者(18%)接受了125次脊柱手术。术前能行走的76例患者(87%)中,大多数(98%)术后仍能行走。术前不能行走的11例患者(13%)中,4例患者术后3个月存活,其中3例(75%)恢复了行走能力。术前VAS中位数为6,出院时以及术后3、6和12个月显著降至中位数2分(所有时间点P<0.001)。共有39%的患者发生并发症;87%为早期(手术30天内),13%为晚期。当固定五个或更多节段时,早期严重手术并发症明显更多。对于 specifically 来自乳腺癌的脊柱转移患者,积极的手术治疗可显著缓解疼痛,并保留或改善神经功能,并发症发生率可接受且较低。